ArticleScientific reports2024

Improved antitumor effectiveness of oncolytic HSV-1 viruses engineered with IL-15/IL-15Rα complex combined with oncolytic HSV-1-aPD1 targets colon cancer.

Zongfeng Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.